what?

$LAOPU GOLD(06181)$ new store in Singapore will officially open on June 21. This will be the brand's first overseas store.Who is Laopu Gold?Over the past few months, Laopu Gold has taken both the consumer and capital markets by storm, becoming a hot topic. On June 5, its share price broke past HK$1,000, reaching a high of HK$1,015 before closing at HK$904, making it the new “king of Hong Kong stocks.” Despite a recent pullback, Laopu Gold’s stock is up 241% year-to-date, significantly outperforming other gold stocks. Since its IPO in July 2024, the stock has surged more than 10x in less than a year.In China, Laopu Gold continues to see long queues at premium shopping malls. The craze has drawn attention from the global luxury sect

$三花智控(02050)$  

Hundreds of companies are lining up for IPOs in Hong Kong, with the $HKEX(00388)$ share price expected to surge by 40% this year. The target price for HKEX has been raised to HKD 470.The Hong Kong IPO market has shown a strong recovery momentum in 2025, and the share price of $HKEX(00388)$ is also expected to see a significant increase. $HKEX(00388)$ is a listed company of the Hong Kong Stock Exchange, and its share price performance is directly affected by market activity and the heat of the IPO market. Below is the relevant analysis and expectations:As of June 2025, the Hong Kong IPO market continues to be highly active, with a significant increase in the nu

Wah. Hard to say if smart play anot eh. But honestly, HK stocks are not for me la. Sg stocks already can't keep up, US stocks already can't eyeball (doff tinezone), how to see HK stocks. And, I almost got burnt by those get rich schemes whereby a cartel of traders add you to some telegram group and have everyone trade a particular HK stock tgt. It was scary.  @BABY SPACEROCK  @LULU ROCKET  @SPACE ROCKET  

Smart play? NAH. Not into HK stocks nor HK IPO. Not worth meddling into such risks.

NOT INTO HK IPOS. PLS. CANT EVEN COPE WITH US MARKET ALREADY. NO BANDWIDTH FOR HK MARKET. @JiaDeName  @LULU ROCKET  

🚀🔥Rushing into Hong Kong IPOs: Is It Smart Investing or Just FOMO? Hong Kong IPOs are undeniably red-hot right now. In the first half of 2025 alone, the Hong Kong Stock Exchange raised a staggering $12.8 billion—far exceeding the Nasdaq ($7.6 billion) and the New York Stock Exchange ($7.0 billion). Even more eye-opening, 70–80% of recent HK IPOs have ended up profitable shortly after listing, a rate that has investors rushing to join the next big IPO wave.🌊💰 But as experienced investors know, chasing IPO fever can sometimes be more hype than substance. So, let's carefully break down whether this is truly a strategic move or merely Fear Of Missing Out (FOMO). 🎯Why Are Hong Kong IPOs Gaining Such Momentum? Several factors underpin this impressive surge: • Improved Investor Access: Retail inv

The Hong Kong Stock Exchange ( $HKEX(00388)$ ) is stealing the global IPO spotlight in 2025, raising $12.8 billion in the first half, outpacing Nasdaq’s $7.6 billion and NYSE’s $7.0 billion. With 70-80% of recent Hong Kong IPOs proving profitable, investors from China to Singapore are jumping in, fueled by a surge in subscription interest. Sanhua Holdings, currently open for subscription, is a standout, aiming to raise HK$8.12 billion ($1.03 billion) with strong backing from global investors. But is this rush driven by fear of missing out (FOMO) or a calculated move? Should you dive into Hong Kong IPOs like Sanhua or chase U.S. IPOs like Circle? This report explores the drivers, risks, and opportunities to help you decide. Hong Kong’s IPO Boom: W

1.Hong Kong $HSI(HSI)$ $HSTECH(HSTECH)$ IPOS1.1 Last week’s Listings and First-Day Performance (3 companies)$NEWTREND GROUP(02573)$ A producer of food-grade sucralose and glycine additives. First-day performance: +21%.$RONGTA TECH(09881)$ : A provider of AIDC devices and solutions. First-day performance: +42%.$METALIGHT(02605)$ : A leading public transportation information service provider. First-day performance: -30%.1.2 HK IPOs in Progress (4 companies)$HAITIAN FLAV(03288)$ (referred to as "the 'Soy Sauce King'"): A leading compa

🌟🌟🌟In a world where IPOs come and go   Foshan Haitian Flavouring and Food Co. $HAITIAN FLAV(03288)$ brings something rare to the table - Heritage backed by numbers.  With roots dating back to the Ming Dynasty and a reputation as the world's largest soy sauce producer, this centuries old culinary titan is now setting its sights on global dominance with a HKD 10 Billion (USD 1.27 billion) secondary listing in Hong Kong on June 19. From Imperial Kitchen to International Shelves  Officially founded in 1955 but with a history steeped in imperial tradition, Haitian has become synonymous with Chinese condiments.  Its products includes Soy sauce, its flagship item, Oyster Sauce,  vinegars, cooking wine as well as Ferme

This week, the Hong Kong stock market saw an initial rise, but then a dip, with $HSI(HSI)$ ending up just 0.42%.CPI and PPI Data: A Mixed BagOn Monday, China’s National Bureau of Statistics released May’s CPI and PPI data. The Consumer Price Index (CPI) dropped by 0.1% year-on-year, while the core CPI, excluding food and energy, rose 0.6%—a slight uptick from the previous month. The Producer Price Index (PPI) fell by 0.4% month-on-month and saw a larger year-on-year drop of 3.3%. Despite weak data, the market remains hopeful.Positive News: US-China Trade TalksGood news came from the US-China trade talks earlier this week in London. Both sides reached a consensus on a framework to implement key agreements from the June 5th phone call between leaders

Offer amount is ~$345.4M. Here’s a quick summary of some red flags we spotted in their most recent S-1 filings. 📝ImageImageImage⚠️ Disclaimer: Just because we're posting this summary does not mean it's a smart idea to short any IPO, let alone in the current investing climate. In any case, here goes:💸 Persistent and Widening Net Losses:Net loss attributable to Voyager Technologies, Inc. was $62.1 million in 2024 (up from $25.4 million in 2023) and $26.9 million for Q1 2025 (up from $14.8 million in Q1 2024).Loss before income taxes was $67.3 million in 2024 (up from $24.9 million in 2023).Accumulated deficit stood at $308.1 million as of March 31, 2025.💸 Negative and Worsening Cash Flow from Operations:Cash used in operating activities was $25.5 million for the year ended Dec 31, 2024 (an i

$Voyager Technologies, Inc.(VOYG)$ is set to make its debut on the New York Stock Exchange (NYSE) today, June 11, 2025, under the ticker symbol "VOYG." ImageThe company has priced its initial public offering (IPO) at $31.00 per share, above its expected range of $26.00 to $29.00. This upsized offering includes 12,348,387 shares, raising approximately $382.85 million. Additionally, underwriters have a 30-day option to purchase up to 1,852,258 additional shares.ImageCompany OverviewVoyager Technologies is a defense and space technology company focused on delivering transformative, mission-critical solutions. Its core business segments include Defense & National Security, Space Solutions, and Starlab Space Stations. The company's work spans commu

$CATL(03750)$ $BYD COMPANY(01211)$ $HSI(HSI)$ $MIXUE GROUP(02097)$ $Tesla Motors(TSLA)$ 🔥⚡ CATL’s Hong Kong 🇭🇰 IPO: A Geopolitical Gambit Redefining Global Capital Flows ⚡🔥 Overview: Why CATL’s IPO Ignites Markets Contemporary Amperex Technology Co. Ltd. (CATL), the global leader in electric vehicle (EV) ⚡️ batteries, launched a seismic Hong Kong IPO on 20May25, raising HK$35.7 billion ($4.6B USD) and soaring 16.4% on debut. Hong Kong’s IPO market, with $18.7B raised in Q1 2025 and over $25.8B YTD, is outshining global rivals, signaling Asia’s rise as a capital hub. Amid 🇺🇸 U.

Hmmm 🤔 HK catching up with the string of 💪 potential pharmaceutical stocks [OMG] Time to add them into my watchlist 👀.... 02629 & 09606 👀.

🌟🌟🌟Mirxes-B $MIRXES-B(02629)$ is a Singapore based biotechnology company that uses cutting edge microRNA technology to develop diagnostic solutions for early detection of diseases. Their tests like the GASTROClear blood based panel are designed to screen for cancers as well as cardiovascular, metabolic and infectious diseases. The success of Mirxes-B IPO in Hong Kong is due to overwhelming investor enthusiasm and robust market conditions for high growth biotech stocks.  The IPO was oversubscribed too. It is exciting times ahead for Hong Kong IPO markets. @Tiger_comments @TigerStars

🌟🌟🌟The recent IPO of Hengrui Pharmaceuticals $HENGRUI PHARMA(01276)$ is an overwhelming success.  Reports indicate that the IPO was oversubscribed.  On the first day of listing, its share price jumped more than 30%. The strong performance of Hengrui is a reflection of investors confidence in the Chinese health care and pharmaceutical sectors. Hengrui is one of China's leading drug makers and its success underscores the market's belief in its continued growth and innovation. @Tiger_comments @TigerStars @Tiger_SG @Captain